Copyright Reports & Markets. All rights reserved.

Global Enzyme Replacement Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Enzyme Replacement Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Injectable Agents
      • 1.4.3 Oral Agents
    • 1.5 Market by Application
      • 1.5.1 Global Enzyme Replacement Therapy Market Share by Application (2014-2025)
      • 1.5.2 Gaucher Disease
      • 1.5.3 Fabry Disease
      • 1.5.4 MPS Disease
      • 1.5.5 Gastrointestinal Disease
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Enzyme Replacement Therapy Market Size
    • 2.2 Enzyme Replacement Therapy Growth Trends by Regions
      • 2.2.1 Enzyme Replacement Therapy Market Size by Regions (2014-2025)
      • 2.2.2 Enzyme Replacement Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Enzyme Replacement Therapy Market Size by Manufacturers
      • 3.1.1 Global Enzyme Replacement Therapy Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Enzyme Replacement Therapy Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Enzyme Replacement Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Enzyme Replacement Therapy Key Players Head office and Area Served
    • 3.3 Key Players Enzyme Replacement Therapy Product/Solution/Service
    • 3.4 Date of Enter into Enzyme Replacement Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Enzyme Replacement Therapy Market Size by Type (2014-2019)
    • 4.2 Global Enzyme Replacement Therapy Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Enzyme Replacement Therapy Market Size (2014-2019)
    • 5.2 Enzyme Replacement Therapy Key Players in United States
    • 5.3 United States Enzyme Replacement Therapy Market Size by Type
    • 5.4 United States Enzyme Replacement Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Enzyme Replacement Therapy Market Size (2014-2019)
    • 6.2 Enzyme Replacement Therapy Key Players in Europe
    • 6.3 Europe Enzyme Replacement Therapy Market Size by Type
    • 6.4 Europe Enzyme Replacement Therapy Market Size by Application

    7 China

    • 7.1 China Enzyme Replacement Therapy Market Size (2014-2019)
    • 7.2 Enzyme Replacement Therapy Key Players in China
    • 7.3 China Enzyme Replacement Therapy Market Size by Type
    • 7.4 China Enzyme Replacement Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Enzyme Replacement Therapy Market Size (2014-2019)
    • 8.2 Enzyme Replacement Therapy Key Players in Japan
    • 8.3 Japan Enzyme Replacement Therapy Market Size by Type
    • 8.4 Japan Enzyme Replacement Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Enzyme Replacement Therapy Market Size (2014-2019)
    • 9.2 Enzyme Replacement Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Enzyme Replacement Therapy Market Size by Type
    • 9.4 Southeast Asia Enzyme Replacement Therapy Market Size by Application

    10 India

    • 10.1 India Enzyme Replacement Therapy Market Size (2014-2019)
    • 10.2 Enzyme Replacement Therapy Key Players in India
    • 10.3 India Enzyme Replacement Therapy Market Size by Type
    • 10.4 India Enzyme Replacement Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Enzyme Replacement Therapy Market Size (2014-2019)
    • 11.2 Enzyme Replacement Therapy Key Players in Central & South America
    • 11.3 Central & South America Enzyme Replacement Therapy Market Size by Type
    • 11.4 Central & South America Enzyme Replacement Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 Sanofi
      • 12.1.1 Sanofi Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Enzyme Replacement Therapy Introduction
      • 12.1.4 Sanofi Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.1.5 Sanofi Recent Development
    • 12.2 Shire
      • 12.2.1 Shire Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Enzyme Replacement Therapy Introduction
      • 12.2.4 Shire Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.2.5 Shire Recent Development
    • 12.3 BioMarin
      • 12.3.1 BioMarin Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Enzyme Replacement Therapy Introduction
      • 12.3.4 BioMarin Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.3.5 BioMarin Recent Development
    • 12.4 AbbVie
      • 12.4.1 AbbVie Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Enzyme Replacement Therapy Introduction
      • 12.4.4 AbbVie Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.4.5 AbbVie Recent Development
    • 12.5 Alexion
      • 12.5.1 Alexion Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Enzyme Replacement Therapy Introduction
      • 12.5.4 Alexion Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.5.5 Alexion Recent Development
    • 12.6 Allergan
      • 12.6.1 Allergan Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Enzyme Replacement Therapy Introduction
      • 12.6.4 Allergan Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.6.5 Allergan Recent Development
    • 12.7 Horizon Pharma
      • 12.7.1 Horizon Pharma Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Enzyme Replacement Therapy Introduction
      • 12.7.4 Horizon Pharma Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.7.5 Horizon Pharma Recent Development
    • 12.8 Johnson & Johnson
      • 12.8.1 Johnson & Johnson Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Enzyme Replacement Therapy Introduction
      • 12.8.4 Johnson & Johnson Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.8.5 Johnson & Johnson Recent Development
    • 12.9 Actelion
      • 12.9.1 Actelion Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Enzyme Replacement Therapy Introduction
      • 12.9.4 Actelion Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.9.5 Actelion Recent Development
    • 12.10 Recordati Rare Diseases
      • 12.10.1 Recordati Rare Diseases Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Enzyme Replacement Therapy Introduction
      • 12.10.4 Recordati Rare Diseases Revenue in Enzyme Replacement Therapy Business (2014-2019)
      • 12.10.5 Recordati Rare Diseases Recent Development
    • 12.11 Pfizer
    • 12.12 Digestive Care
    • 12.13 Leadiant Biosciences

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.
      The classification of enzyme replacement therapy includes injectable agents and oral agents, and the revenue proportion of injectable agents in 2017 is about 62.38%, and the proportion is in increasing trend from 2013 to 2017.
      North America is the largest consumption place, with a consumption market share nearly 70.77% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 21.25%.
      Market competition is intense. Sanofi, Shire, BioMarin, AbbVie , etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
      In 2018, the global Enzyme Replacement Therapy market size was 7400 million US$ and it is expected to reach 21000 million US$ by the end of 2025, with a CAGR of 14.0% during 2019-2025.

      This report focuses on the global Enzyme Replacement Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Enzyme Replacement Therapy development in United States, Europe and China.

      The key players covered in this study
      Sanofi
      Shire
      BioMarin
      AbbVie 
      Alexion
      Allergan
      Horizon Pharma
      Johnson & Johnson
      Actelion
      Recordati Rare Diseases
      Pfizer
      Digestive Care
      Leadiant Biosciences

      Market segment by Type, the product can be split into
      Injectable Agents
      Oral Agents

      Market segment by Application, split into
      Gaucher Disease
      Fabry Disease
      MPS Disease
      Gastrointestinal Disease
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Enzyme Replacement Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Enzyme Replacement Therapy development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Enzyme Replacement Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now